During the past decade, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 100 clinical trials were completed, i.e. on average, 101% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 29 clinical trials were completed. i.e. 72.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 73 trials, followed by "Georgetown University" with 57 trials sponsored, "Children's Oncology Group" with 45 trials sponsored, "Gynecologic Oncology Group" with 20 trials sponsored and "National Cancer Institute (NCI)" with 20 trials sponsored. Other sponsors include 178 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 207 trials as a collaborator, "Cancer and Leukemia Group B" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 147 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" are "Breast Cancer" (44 trials), "Lymphoma" (31 trials), "Leukemia" (29 trials), "Colorectal Cancer" (24 trials) and "Lung Cancer" (20 trials). Many other conditions were trialed in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" in a lesser frequency.

Most popular intervention types in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" are "Drug" (325 trials), "Biological" (91 trials), "Procedure" (55 trials), "Radiation" (44 trials) and "Other" (40 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (32 trials), "filgrastim" (29 trials), "doxorubicin hydrochloride" (28 trials), "etoposide" (28 trials) and "radiation therapy" (26 trials). Other intervention names were less common.

The vast majority of trials in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" are 320 trials for "All" genders, 60 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center". undefined are not yet recruiting, 23 are recruiting, 39 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 251 completed trials in Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, 2 suspended trials, and 58 terminated clinical trials to date.

Out of the total trials that were conducted in Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, 86 "Phase 1" clinical trials were conducted, 199 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".